Mycotoxicity (Mold Toxicity)
Mycotoxicity, often referred to as mold toxicity, is a condition that can contribute to persistent, multisystem symptoms and is frequently overlooked in conventional medical evaluations. Many individuals affected by mold exposure undergo extensive testing, only to be told that results are normal or inconclusive — despite ongoing symptoms that significantly affect quality of life.
In my clinical experience, mycotoxicity is sometimes an important piece of the puzzle in individuals with chronic illness, particularly when symptoms are unexplained or persistent. Chronic fatigue and brain fog are common, though symptoms may affect multiple body systems.
Early in my practice, I was readily diagnosing and treating Lyme and other tick-borne infections. While many people recovered, it became clear that something important was being missed in a subset of patients. Through additional training with Ritchie Shoemaker MD, Neil Nathan MD, and Jill Crista ND, I learned how frequently mycotoxicity can contribute to persistent symptoms and how essential it is to identify and properly address mold-related illness. This deeper understanding fundamentally changed how I evaluate and support individuals with chronic, complex conditions.
Addressing mold exposure is not always simple. For many, it may involve difficult decisions such as remediation, relocating, or reassessing living or work environments — choices that can carry significant financial, logistical, and emotional weight. I recognize how overwhelming this process can feel. At the same time, I have witnessed how meaningful these changes can be. When environmental factors are addressed and then appropriate therapeutic support is provided, patients can experience a resolution of symptoms. Seeing individuals regain mental clarity, energy, and a sense of their lives again is one of the most meaningful aspects of this work.
This page is intended to provide clear, grounded education about mycotoxicity — what it is, how exposure occurs, why it is often missed, and how it may be addressed within an individualized, whole-person framework.
In my clinical experience, mycotoxicity is sometimes an important piece of the puzzle in individuals with chronic illness, particularly when symptoms are unexplained or persistent. Chronic fatigue and brain fog are common, though symptoms may affect multiple body systems.
Early in my practice, I was readily diagnosing and treating Lyme and other tick-borne infections. While many people recovered, it became clear that something important was being missed in a subset of patients. Through additional training with Ritchie Shoemaker MD, Neil Nathan MD, and Jill Crista ND, I learned how frequently mycotoxicity can contribute to persistent symptoms and how essential it is to identify and properly address mold-related illness. This deeper understanding fundamentally changed how I evaluate and support individuals with chronic, complex conditions.
Addressing mold exposure is not always simple. For many, it may involve difficult decisions such as remediation, relocating, or reassessing living or work environments — choices that can carry significant financial, logistical, and emotional weight. I recognize how overwhelming this process can feel. At the same time, I have witnessed how meaningful these changes can be. When environmental factors are addressed and then appropriate therapeutic support is provided, patients can experience a resolution of symptoms. Seeing individuals regain mental clarity, energy, and a sense of their lives again is one of the most meaningful aspects of this work.
This page is intended to provide clear, grounded education about mycotoxicity — what it is, how exposure occurs, why it is often missed, and how it may be addressed within an individualized, whole-person framework.
What Is Mycotoxicity?
Mycotoxicity, often referred to as mold toxicity, is a form of environmentally acquired illness (EAI). EAIs describe chronic health conditions driven by environmental exposures and biological stressors, most commonly unhealthy indoor air from water-damaged buildings and persistent infections.
Mycotoxins are toxic compounds produced by certain molds. When inhaled or absorbed, these toxins may contribute to chronic inflammation, immune dysregulation, neurological symptoms, and impaired detoxification processes. Mycotoxicity is not the same as a mold allergy (sneezing, itchy/watery eyes, nasal congestion, cough, asthma, chest tightness, shortness of breath or rash). Some individuals may exhibit symptoms of both conditions. In mycotoxicity, which is our focus here, exposure can lead to multisystem illness that persists even after leaving the contaminated environment.
Not everyone exposed to mold develops mycotoxicity. Individual susceptibility varies and may be influenced by genetics, immune function, cumulative environmental exposures, and the presence of underlying or persistent infections.
Mycotoxins are toxic compounds produced by certain molds. When inhaled or absorbed, these toxins may contribute to chronic inflammation, immune dysregulation, neurological symptoms, and impaired detoxification processes. Mycotoxicity is not the same as a mold allergy (sneezing, itchy/watery eyes, nasal congestion, cough, asthma, chest tightness, shortness of breath or rash). Some individuals may exhibit symptoms of both conditions. In mycotoxicity, which is our focus here, exposure can lead to multisystem illness that persists even after leaving the contaminated environment.
Not everyone exposed to mold develops mycotoxicity. Individual susceptibility varies and may be influenced by genetics, immune function, cumulative environmental exposures, and the presence of underlying or persistent infections.
Sources of Mold Exposure
Mold exposure most commonly occurs in water-damaged indoor environments. Buildings that have experienced roof leaks, plumbing leaks, flooding, or chronic moisture problems can become contaminated with molds and bacteria that produce toxins. These toxins may be inhaled by occupants and, in susceptible individuals, contribute to illness.
Importantly, mold exposure is not always obvious. Mold may be present even when it is not visible or when there is no noticeable odor. Older buildings may have had an unknown history of water damage. Modern buildings are often tightly sealed for energy efficiency, which can allow mold-related toxins to accumulate indoors and increase exposure over time.
While outdoor mold and environmental toxins can also affect health, indoor exposures tend to be more impactful because toxins become concentrated in building materials. Common sources of indoor exposure may include homes, apartments, cars, garages, sheds, workplaces, schools, or other buildings with a history of water intrusion or poor ventilation.
Importantly, mold exposure is not always obvious. Mold may be present even when it is not visible or when there is no noticeable odor. Older buildings may have had an unknown history of water damage. Modern buildings are often tightly sealed for energy efficiency, which can allow mold-related toxins to accumulate indoors and increase exposure over time.
While outdoor mold and environmental toxins can also affect health, indoor exposures tend to be more impactful because toxins become concentrated in building materials. Common sources of indoor exposure may include homes, apartments, cars, garages, sheds, workplaces, schools, or other buildings with a history of water intrusion or poor ventilation.
Signs and Symptoms of Mycotoxicity
Symptoms associated with mycotoxicity can vary widely and may affect multiple body systems.
Commonly reported symptoms may include:
Symptoms may fluctuate over time and often worsen with continued exposure or during periods of physiological stress. Because these symptoms overlap with many other conditions, individuals may undergo extensive evaluation without clear answers when mycotoxicity is not considered.
Commonly reported symptoms may include:
- Fatigue or reduced stamina
- Brain fog, memory difficulties, or trouble concentrating
- Headaches or migraines
- Gastrointestinal symptoms, including bloating, nausea or food sensitivities
- Frequent urination or bladder pressure
- Lightheadedness or dizziness
- Heart palpitations
- Mood changes, anxiety, or irritability
- Sleep disturbances
- Heightened sensitivity to chemicals, odors, or environmental exposures
Symptoms may fluctuate over time and often worsen with continued exposure or during periods of physiological stress. Because these symptoms overlap with many other conditions, individuals may undergo extensive evaluation without clear answers when mycotoxicity is not considered.
Why Mycotoxicity Is Often Missed
Mycotoxicity is frequently overlooked because its symptoms are nonspecific and overlap with many other medical conditions. Often conventionally trained medical professionals do not ask about environmental exposures.
Routine laboratory testing and imaging are often normal or only mildly abnormal in individuals affected by mycotoxicity. When no clear explanation is found, patients may be reassured that nothing serious is wrong, even as symptoms persist or worsen.
Another challenge is that mold exposure is not always obvious. Individuals may not see visible mold, smell musty odors, or recall a clear water-damage event, particularly if exposure occurred in the past or in a workplace, school, or previously occupied home.
Finally, mycotoxicity often occurs alongside other conditions, such as persistent infections, mast cell activation, or autonomic dysfunction. When care is fragmented across multiple specialties, the underlying environmental contribution may remain unrecognized.
For these reasons, mycotoxicity is often identified only after other explanations have been exhausted. A careful clinical history, environmental awareness, and a systems-based approach can be essential in recognizing when mold exposure may be contributing to chronic illness.
Routine laboratory testing and imaging are often normal or only mildly abnormal in individuals affected by mycotoxicity. When no clear explanation is found, patients may be reassured that nothing serious is wrong, even as symptoms persist or worsen.
Another challenge is that mold exposure is not always obvious. Individuals may not see visible mold, smell musty odors, or recall a clear water-damage event, particularly if exposure occurred in the past or in a workplace, school, or previously occupied home.
Finally, mycotoxicity often occurs alongside other conditions, such as persistent infections, mast cell activation, or autonomic dysfunction. When care is fragmented across multiple specialties, the underlying environmental contribution may remain unrecognized.
For these reasons, mycotoxicity is often identified only after other explanations have been exhausted. A careful clinical history, environmental awareness, and a systems-based approach can be essential in recognizing when mold exposure may be contributing to chronic illness.
Testing for Mycotoxicity
Testing for mycotoxicity requires a thoughtful and individualized approach. Because mold-related illness does not consistently produce abnormalities on routine blood work or imaging, specialized testing may be considered when mold exposure is suspected.
One commonly used tool is urine mycotoxin testing, which evaluates mycotoxins the body is actively excreting. Different laboratory technologies may be used for detection.
ELISA-Based Mycotoxin Testing
This method uses antibodies prepared against mycotoxins to detect groups of toxins, which may include:
Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) Testing
This technology directly detects specific mycotoxins, which may include:
Urine mycotoxin testing can provide supportive information, particularly when interpreted alongside symptoms and exposure history.
Blood Testing
In some individuals, blood testing may be used to assess genetic susceptibility and immune response, particularly when features of chronic inflammatory response syndrome (CIRS) are present. This may include HLA-DR and DQ haplotype testing, which evaluates how effectively the immune system presents biotoxins for clearance. In certain cases, impaired toxin presentation can lead to persistent activation of the part of the immune system called the innate immune system. Other biomarkers can also be measured.
Overall, test results are best interpreted in clinical context, guided by symptoms, exposure history, and careful clinical judgment rather than by any single laboratory finding.
One commonly used tool is urine mycotoxin testing, which evaluates mycotoxins the body is actively excreting. Different laboratory technologies may be used for detection.
ELISA-Based Mycotoxin Testing
This method uses antibodies prepared against mycotoxins to detect groups of toxins, which may include:
- Aflatoxins
- Trichothecenes
- Gliotoxin
- Ochratoxin A
- Zearalenone
Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) Testing
This technology directly detects specific mycotoxins, which may include:
- Aflatoxins
- Ochratoxin A
- Trichothecenes
- Zearalenone
- Chaetoglobosin
- Enniatin B
- Gliotoxin
- Mycophenolic Acid
- Sterigmatocystin
- Citrinin
Urine mycotoxin testing can provide supportive information, particularly when interpreted alongside symptoms and exposure history.
Blood Testing
In some individuals, blood testing may be used to assess genetic susceptibility and immune response, particularly when features of chronic inflammatory response syndrome (CIRS) are present. This may include HLA-DR and DQ haplotype testing, which evaluates how effectively the immune system presents biotoxins for clearance. In certain cases, impaired toxin presentation can lead to persistent activation of the part of the immune system called the innate immune system. Other biomarkers can also be measured.
Overall, test results are best interpreted in clinical context, guided by symptoms, exposure history, and careful clinical judgment rather than by any single laboratory finding.
Treatment Considerations for Mycotoxicity
Treatment for mycotoxicity is highly individualized. A foundational principle of care is eliminating ongoing mold exposure, as meaningful recovery is unlikely to occur if exposure continues. This may involve remediation or relocation, depending on the individual situation.
Once exposure has been addressed, treatment often focuses on supporting the body’s ability to eliminate mycotoxins, support detox pathways and decrease inflammation. This may include the use of binding agents to help facilitate toxin removal, along with support for detoxification pathways involving the liver, kidneys, lymphatic system, and gastrointestinal tract. Nutrients such as glutathione may also be used to support removal of mycotoxins and liver support.
Additional supportive strategies may include encouraging sweating, through sauna use when appropriate, to assist with elimination. Addressing fungal colonization, particularly in the nasal passages or gastrointestinal tract, is also an important component of care. Dietary modifications are often recommended to reduce exogenous intake of mold/mycotoxins and support detoxification.
Importantly, treatment must be paced according to each person’s capacity. Some individuals are able to move through detoxification more quickly, while others require a slower, more gradual approach to avoid constipation and symptom flares. Ongoing monitoring and adjustment are essential, with the goal of supporting steady progress rather than overwhelming the system.
Once exposure has been addressed, treatment often focuses on supporting the body’s ability to eliminate mycotoxins, support detox pathways and decrease inflammation. This may include the use of binding agents to help facilitate toxin removal, along with support for detoxification pathways involving the liver, kidneys, lymphatic system, and gastrointestinal tract. Nutrients such as glutathione may also be used to support removal of mycotoxins and liver support.
Additional supportive strategies may include encouraging sweating, through sauna use when appropriate, to assist with elimination. Addressing fungal colonization, particularly in the nasal passages or gastrointestinal tract, is also an important component of care. Dietary modifications are often recommended to reduce exogenous intake of mold/mycotoxins and support detoxification.
Importantly, treatment must be paced according to each person’s capacity. Some individuals are able to move through detoxification more quickly, while others require a slower, more gradual approach to avoid constipation and symptom flares. Ongoing monitoring and adjustment are essential, with the goal of supporting steady progress rather than overwhelming the system.
Mycotoxicity and Chronic Illness
Mycotoxicity is frequently intertwined with chronic illness and may contribute to persistent, multisystem symptoms when recovery has stalled. Ongoing exposure to mold and mycotoxins can place significant stress on the immune, nervous, and detoxification systems, making it more difficult for the body to heal from other conditions.
In some individuals, mycotoxicity may coexist with or exacerbate conditions such as chronic inflammatory response syndrome (CIRS), mast cell activation, autonomic dysfunction, persistent infections, or heightened chemical sensitivity. When these conditions overlap, symptoms may become more complex, variable, and difficult to attribute to a single cause.
Recognizing the role of mycotoxicity within the broader context of chronic illness allows for a more comprehensive and individualized approach to care, particularly for individuals who have not experienced full improvement despite addressing other contributing factors.
Mold exposure may also contribute to immune dysregulation and mast cell activation. Learn more about Mast Cell Activation Syndrome (MCAS).
For many, identifying and addressing mycotoxicity becomes an important turning point in the healing process.
In some individuals, mycotoxicity may coexist with or exacerbate conditions such as chronic inflammatory response syndrome (CIRS), mast cell activation, autonomic dysfunction, persistent infections, or heightened chemical sensitivity. When these conditions overlap, symptoms may become more complex, variable, and difficult to attribute to a single cause.
Recognizing the role of mycotoxicity within the broader context of chronic illness allows for a more comprehensive and individualized approach to care, particularly for individuals who have not experienced full improvement despite addressing other contributing factors.
Mold exposure may also contribute to immune dysregulation and mast cell activation. Learn more about Mast Cell Activation Syndrome (MCAS).
For many, identifying and addressing mycotoxicity becomes an important turning point in the healing process.
Who Is at Higher Risk?
Not everyone exposed to mold develops mycotoxicity. Individual susceptibility varies, and certain factors may increase the likelihood of experiencing more significant or persistent symptoms.
People who may be at higher risk include those with repeated or prolonged exposure to water-damaged buildings, underlying immune dysregulation, genetic factors that affect detoxification, or co-existing conditions such as chronic infections, mast cell activation, or autoimmune disorders. Individuals with a history of multiple environmental sensitivities may also be more vulnerable.
People who may be at higher risk include those with repeated or prolonged exposure to water-damaged buildings, underlying immune dysregulation, genetic factors that affect detoxification, or co-existing conditions such as chronic infections, mast cell activation, or autoimmune disorders. Individuals with a history of multiple environmental sensitivities may also be more vulnerable.
Prevention and Environmental Considerations
If there is concern for mold exposure in the home or workplace, an important first step is working with a qualified indoor environmental professional (IEP) or mold inspector. These professionals are trained to assess buildings for moisture problems, mold, and other environmental contributors that may impact health.
A helpful resource for finding an IEP is the International Society for Environmentally Acquired Illness (ISEAI), which maintains a directory of professionals familiar with working with medically sensitive individuals:
👉 https://iseai.org/iep-list/
Indoor environmental professionals typically perform on-site inspections using visual assessment and diagnostic tools, recommend and interpret appropriate testing, and provide a written report outlining findings and remediation recommendations. They may also help guide or oversee a remediation plan. Depending on the situation, recommendations may include improving ventilation, controlling humidity with a dehumidifier, and replacing water-damaged building materials.
Remediators, in contrast, focus on the physical removal of contaminated materials and mold-affected building components using established protocols. When remediation is needed, it is important to work with professionals who are familiar with—or willing to follow—the IICRC S520 standard, which outlines best practices for mold remediation.
Preventing ongoing or future mold exposure is an important part of protecting long-term health, particularly for individuals who have already experienced symptoms related to mycotoxicity. Water intrusion is a primary driver of indoor mold growth. Roof leaks, plumbing leaks, flooding, indoor humidity above 50%, and poorly ventilated areas can all contribute to mold growth, even when visible mold is not present. In many cases, setting a dehumidifier to 45% humidity and using air purification can be helpful supportive measures.
Environmental decisions can carry significant emotional and financial weight. Prevention and remediation strategies are best approached thoughtfully and realistically, with guidance tailored to the individual situation and overall health goals.
A helpful resource for finding an IEP is the International Society for Environmentally Acquired Illness (ISEAI), which maintains a directory of professionals familiar with working with medically sensitive individuals:
👉 https://iseai.org/iep-list/
Indoor environmental professionals typically perform on-site inspections using visual assessment and diagnostic tools, recommend and interpret appropriate testing, and provide a written report outlining findings and remediation recommendations. They may also help guide or oversee a remediation plan. Depending on the situation, recommendations may include improving ventilation, controlling humidity with a dehumidifier, and replacing water-damaged building materials.
Remediators, in contrast, focus on the physical removal of contaminated materials and mold-affected building components using established protocols. When remediation is needed, it is important to work with professionals who are familiar with—or willing to follow—the IICRC S520 standard, which outlines best practices for mold remediation.
Preventing ongoing or future mold exposure is an important part of protecting long-term health, particularly for individuals who have already experienced symptoms related to mycotoxicity. Water intrusion is a primary driver of indoor mold growth. Roof leaks, plumbing leaks, flooding, indoor humidity above 50%, and poorly ventilated areas can all contribute to mold growth, even when visible mold is not present. In many cases, setting a dehumidifier to 45% humidity and using air purification can be helpful supportive measures.
Environmental decisions can carry significant emotional and financial weight. Prevention and remediation strategies are best approached thoughtfully and realistically, with guidance tailored to the individual situation and overall health goals.
Schedule a Consultation
Navigating mycotoxicity can feel overwhelming, particularly when symptoms have persisted for months or years without clear answers. A thoughtful, individualized approach can help bring clarity and direction, even in complex cases.
My work focuses on helping individuals understand how environmental exposures may be contributing to their symptoms and on guiding a step-by-step plan that prioritizes safety, pacing, and whole-person care. Evaluation and recommendations are tailored to each individual’s history, exposures, symptoms, and goals.
Care is provided via telehealth, with services adapted based on location and licensure. Specific details are reviewed during the intake and consent process to ensure clarity and transparency.
If you are seeking guidance related to mold exposure, chronic symptoms, or mycotoxicity, working together may help identify next steps and support progress toward improved health and resilience.
To learn more about scheduling options or to schedule an appointment, please visit:
👉 Schedule an Appointment
Taking the next step begins with understanding your options and determining what support may be most appropriate for you.
My work focuses on helping individuals understand how environmental exposures may be contributing to their symptoms and on guiding a step-by-step plan that prioritizes safety, pacing, and whole-person care. Evaluation and recommendations are tailored to each individual’s history, exposures, symptoms, and goals.
Care is provided via telehealth, with services adapted based on location and licensure. Specific details are reviewed during the intake and consent process to ensure clarity and transparency.
If you are seeking guidance related to mold exposure, chronic symptoms, or mycotoxicity, working together may help identify next steps and support progress toward improved health and resilience.
To learn more about scheduling options or to schedule an appointment, please visit:
👉 Schedule an Appointment
Taking the next step begins with understanding your options and determining what support may be most appropriate for you.
All material provided on this website is provided for informational or educational purposes only,
and is not intended as a substitute for the advice provided by your physician or healthcare professional.